Torthaí cuardaigh - Marjan A. Versnel
- 1 - 20 toradh as 22 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini review de réir Bart Humer, Willem A. Dik, Marjan A. Versnel
Foilsithe / Cruthaithe 2025Revisão -
2
Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome de réir Wouter Beumer, Roosmarijn C. Drexhage, Harm de Wit, Marjan A. Versnel, Hemmo A. Drexhage, Dan Cohen
Foilsithe / Cruthaithe 2012Artigo -
3
Increased Serum Levels of MRP-8/14 in Type 1 Diabetes Induce an Increased Expression of CD11b and an Enhanced Adhesion of Circulating Monocytes to Fibronectin de réir Gerben Bouma, Wai Kwan Lam-Tse, Annet F. Wierenga‐Wolf, Hemmo A. Drexhage, Marjan A. Versnel
Foilsithe / Cruthaithe 2004Artigo -
4
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial de réir Iris L. A. Bodewes, Jacques‐Eric Gottenberg, Cornelia G van Helden-Meeuwsen, Xavier Mariette, Marjan A. Versnel
Foilsithe / Cruthaithe 2019Artigo -
5
Systemic increase in type I interferon activity in Sjögren's syndrome: A putative role for plasmacytoid dendritic cells de réir Manon E. Wildenberg, Cornelia G van Helden-Meeuwsen, J.P. van de Merwe, Hemmo A. Drexhage, Marjan A. Versnel
Foilsithe / Cruthaithe 2008Artigo -
6
The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma de réir Jan‐Bas Prins, Kathy Williamson, Marga Kamp, Ed J. Van Hezik, Theodorus van der Kwast, Anne Hagemeijer, Marjan A. Versnel
Foilsithe / Cruthaithe 1998Artigo -
7
An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces de réir Roosmarijn C. Drexhage, Thomas A. Hoogenboezem, Dan Cohen, Marjan A. Versnel, Willem A. Nolen, Nico J.M. van Beveren, Hemmo A. Drexhage
Foilsithe / Cruthaithe 2011Artigo -
8
Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients de réir Roosmarijn C. Drexhage, Leonie van der Heul-Nieuwenhuijsen, Roos C. Padmos, Nico van Beveren, Dan Cohen, Marjan A. Versnel, Willem A. Nolen, Hemmo A. Drexhage
Foilsithe / Cruthaithe 2010Artigo -
9
Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome de réir Tim Both, Ewout J. Hoorn, Robert Zietse, Jan van Laar, Virgil A. S. H. Dalm, Zana Brkić, Marjan A. Versnel, P. Martin van Hagen, Paul Van Daele
Foilsithe / Cruthaithe 2014Artigo -
10
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use de réir Lucas L. van den Hoogen, Ruth Fritsch‐Stork, Marjan A. Versnel, Ronald H. W. M. Derksen, Joël A. G. van Roon, Timothy R. D. J. Radstake
Foilsithe / Cruthaithe 2016Carta -
11
Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors? de réir M. J. Wahadat, Iris L. A. Bodewes, Naomi I. Maria, Cornelia G van Helden-Meeuwsen, Annette van Dijk-Hummelman, Eline C. Steenwijk, Sylvia Kamphuis, Marjan A. Versnel
Foilsithe / Cruthaithe 2018Artigo -
12
The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes de réir Wouter Beumer, Sinead M. Gibney, Roosmarijn C. Drexhage, Lorena Pont‐Lezica, Janine Doorduin, Hans Klein, Johann Steiner, Thomas J. Connor, Andrew Harkin, Marjan A. Versnel, Hemmo A. Drexhage
Foilsithe / Cruthaithe 2012Revisão -
13
Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy de réir Kornvalee Meesilpavikkai, Willem A. Dik, Benjamin Schrijver, Cornelia G van Helden-Meeuwsen, Marjan A. Versnel, P. Martin van Hagen, Emilia K. Bijlsma, Claudia Ruivenkamp, Margreet J. Oele, Virgil A. S. H. Dalm
Foilsithe / Cruthaithe 2019Artigo -
14
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression de réir Zana Brkić, Naomi I. Maria, Cornelia G van Helden-Meeuwsen, J.P. van de Merwe, Paul Van Daele, Virgil A. S. H. Dalm, Manon E. Wildenberg, Wouter Beumer, Hemmo A. Drexhage, Marjan A. Versnel
Foilsithe / Cruthaithe 2012Artigo -
15
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome de réir Naomi I. Maria, Zana Brkić, Matti Waris, Cornelia G van Helden-Meeuwsen, Kim C. Heezen, J.P. van de Merwe, Paul Van Daele, Virgil A. S. H. Dalm, Hemmo A. Drexhage, Marjan A. Versnel
Foilsithe / Cruthaithe 2013Artigo -
16
Amlexanox inhibits production of type I interferon and suppresses B cell differentiation<i>in vitro</i>: a possible therapeutic option for systemic lupus erythematosus and other sy... de réir Albin Björk, M. J. Wahadat, Maria Sánchez-Blázquez, Merijn Braams, Jasper Rip, Sander J van Tilburg, Cornelia G van Helden-Meeuwsen, Sylvia Kamphuis, Thierry P. P. van den Bosch, Zana Brkić, Marjan A. Versnel
Foilsithe / Cruthaithe 2025Artigo -
17
Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity de réir Iris L. A. Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, Naomi I. Maria, Jessica Tarn, Dennis Lendrem, Marco W.J. Schreurs, Eline C. Steenwijk, Paul Van Daele, Tim Both, Simon Bowman, Bridget Griffiths, Wan‐Fai Ng, Marjan A. Versnel
Foilsithe / Cruthaithe 2018Artigo -
18
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice de réir Javier Rodríguez‐Carrio, Agata Burska, Philip G. Conaghan, Willem A. Dik, Robert Biesen, Maija‐Leena Eloranta, Giulio Cavalli, Marianne E Visser, Dimitrios T. Boumpas, George Βertsias, Marie Wahren‐Herlenius, Jan Rehwinkel, Marie‐Louise Frémond, Mary K. Crow, Lars Rönnblom, Marjan A. Versnel, Edward M Vital
Foilsithe / Cruthaithe 2023Artigo -
19
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider de réir Agata Burska, Javier Rodríguez‐Carrio, Robert Biesen, Willem A. Dik, Maija‐Leena Eloranta, Giulio Cavalli, Marjolein Visser, Dimitrios T. Boumpas, George Βertsias, Marie Wahren‐Herlenius, Jan Rehwinkel, Marie‐Louise Frémond, Mary K. Crow, Lars Rönnblom, Philip G. Conaghan, Marjan A. Versnel, Edward M Vital
Foilsithe / Cruthaithe 2023Revisão -
20
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to c... de réir Javier Rodríguez‐Carrio, Agata Burska, Philip G. Conaghan, Willem A. Dik, Robert Biesen, Maija‐Leena Eloranta, Giulio Cavalli, Marjolein Visser, Dimitrios T. Boumpas, George Βertsias, Marie Wahren‐Herlenius, Jan Rehwinkel, Marie‐Louise Frémond, Mary K. Crow, Lars Rönnblom, Edward M Vital, Marjan A. Versnel
Foilsithe / Cruthaithe 2023Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Immunology
Biology
Internal medicine
Interferon
Genetics
Immune system
Disease
Gene
Monocyte
Biochemistry
Flow cytometry
In vitro
Antibody
CD14
Inflammation
Peripheral blood mononuclear cell
B cell
B-cell activating factor
Bioinformatics
Innate immune system
Interferon type I
Receptor
Alternative medicine
Bipolar disorder
Cell
Cell sorting
Coronavirus disease 2019 (COVID-19)
Dendritic cell
Endocrinology